C. Moyret-Lalle

发表

The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene.

T. Soussi, A. Puisieux, C. Duriez, 2002, Gene.

p53 induction prevents accumulation of aberrant transcripts in cancer cells.

A. Puisieux, C. Duriez, C. Moyret-Lalle, 2001, Cancer research.

BTG gene expression in the p53‐dependent and ‐independent cellular response to DNA damage

P. Hainaut, A. Puisieux, A. Morel, 2000, Molecular carcinogenesis.

Absence of p53-dependent induction of the metastatic suppressor KAI1 gene after DNA damage

A. Puisieux, C. Duriez, N. Falette, 2000, Oncogene.

F. Bertucci, D. Birnbaum, D. Cox, 2017, Nature Medicine.

Contribution of cell culture, RNA extraction, and reverse transcription to the measurement error in quantitative reverse transcription polymerase chain reaction-based gene expression quantification.

N. Voirin, R. Écochard, C. Moyret-Lalle, 2009, Analytical biochemistry.

Epithelial-mesenchymal transition transcription factors and miRNAs: "Plastic surgeons" of breast cancer.

A. Puisieux, C. Moyret-Lalle, Emmanuelle M L Ruiz, 2014, World journal of clinical oncology.

Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer

Y. Drouet, N. Voirin, A. Viari, 2018, Scientific Reports.

Quantifying local malignant adaptation in tissue‐specific evolutionary trajectories by harnessing cancer’s repeatability at the genetic level

S. Sugano, P. Martinez, A. Puisieux, 2018, bioRxiv.

Quantifying local malignant adaptation in tissue-specific evolutionary trajectories by harnessing cancer’s repeatability at the genetic level

P. Martinez, A. Puisieux, C. Moyret-Lalle, 2018, bioRxiv.

Epithelial-mesenchymal transition transcription factors and miRNAs: “Plastic surgeons” of breast cancer World Journal of Clinical Oncology

A. Puisieux, C. Moyret-Lalle, Emmanuelle M L Ruiz, 2014 .

Abstract 1442: Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype

N. Voirin, I. Treilleux, A. Puisieux, 2010 .

Role of EMT in the DNA damage response, double‐strand break repair pathway choice and its implications in cancer treatment

A. Puisieux, C. Moyret-Lalle, H. Seimiya, 2022, Cancer science.

Identification of BTG2, an antiproliferative p53–dependent component of the DNA damage cellular response pathway

R. Berger, A. Puisieux, M. Ozturk, 1996, Nature Genetics.

Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype

N. Voirin, D. Cox, I. Treilleux, 2009, British Journal of Cancer.

EMT Transcription Factor ZEB1 Represses the Mutagenic POLθ-Mediated End-Joining Pathway in Breast Cancers

P. Brousset, A. Puisieux, A. Morel, 2020, Cancer Research.

TIF 1 g Suppresses Tumor Progression by RegulatingMitoticCheckpoints andChromosomal Stability

A. Puisieux, C. Moyret-Lalle, R. Pommier, 2015 .

Epithelial-Mesenchymal Transition and Metastasis: Role of Dicer Expression

C. Moyret-Lalle, S. Courtois-Cox, 2012 .

Heterogeneity and dynamic of EMT through the plasticity of ribosome and mRNA translation.

C. Moyret-Lalle, V. Marcel, H. Mertani, 2022, Biochimica et biophysica acta. Reviews on cancer.

ras, p53 and hpv status in benign and malignant prostate tumors

M. Ozturk, C. Moyret-Lalle, C. Theillet, 1995, International journal of cancer.

Opposite Roles for ZEB1 and TMEJ in the Regulation of Breast Cancer Genome Stability

P. Brousset, A. Puisieux, A. Morel, 2021, Frontiers in Cell and Developmental Biology.

Genomic stability and wild-type p53 function of lymphoblastoid cells with germ-line p53 mutation.

M. Ozturk, C. Moyret-Lalle, Q. Wang, 1995, Oncogene.

Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function

C. Moyret-Lalle, S. Chouaib, A. Larsen, 1997, Oncogene.

TIF1γ Suppresses Tumor Progression by Regulating Mitotic Checkpoints and Chromosomal Stability.

G. Fourel, A. Puisieux, C. Moyret-Lalle, 2015, Cancer research.

Alterations of anaphase-promoting complex genes in human colon cancer cells

T. Lorca, J. Saurin, A. Puisieux, 2003, Oncogene.

Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations.

S. Schraub, D. Frappaz, S. Mazoyer, 1994, Oncogene.

BTG2, its family and its tutor.

A. Puisieux, C. Duriez, N. Falette, 2004, Bulletin du cancer.

Complexity in the regulation of Dicer expression: Dicer variant proteins are differentially expressed in epithelial and mesenchymal breast cancer cells and decreased during EMT

A. Puisieux, C. Moyret-Lalle, G. Hinkal, 2010, British Journal of Cancer.